Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Treatment-aware Diffusion Probabilistic Model for Longitudinal MRI Generation and Diffuse Glioma Growth Prediction

  • Liu, Qinghui
  • Hovden, Ivar T
  • MacIntosh, Bradley J
  • Grødem, Edvard O.S.
  • Brandal, Peter
  • Sederevicius, Donatas
  • Skogen, Karoline
  • Schellhorn, Till
  • Bjornerud, Atle
  • Emblem, Kyrre E.
  • Fuster García, Elíes|||0000-0002-0716-8960
  • López-Mateu, Carlos
[EN] Diffuse gliomas are malignant brain tumors that grow widespread through the brain. The complex interactions between neoplastic cells and normal tissue, as well as the treatment-induced changes often encountered, make glioma tumor growth modeling challenging. In this paper, we present a novel end-to-end network capable of future predictions of tumor masks and multi-parametric magnetic resonance images (MRI) of how the tumor will look at any future time points for different treatment plans. Our approach is based on cutting-edge diffusion probabilistic models and deep-segmentation neural networks. We included sequential multi-parametric MRI and treatment information as conditioning inputs to guide the generative diffusion process as well as a joint segmentation process. This allows for tumor growth estimates and realistic MRI generation at any given treatment and time point. We trained the model using real-world postoperative longitudinal MRI data with glioma tumor growth trajectories represented as tumor segmentation maps over time. The model demonstrates promising performance across various tasks, including generating high-quality multi-parametric MRI with tumor masks, performing time-series tumor segmentations, and providing uncertainty estimates. Combined with the treatment-aware generated MRI, the tumor growth., This work was supported by the European Union s Horizon 2020 Programme: ERC (European Research Council) Grant Agreement No. 758657-ImPRESS, Helse Sør-Øst Regional Health Authority grants 2021057, 2017073, the Research Council of Norway grants 325971, 261984, and grant PID2021-127110OA-I00 funded by MCIN/AEI/10.13039/501100011033 from Agencia de Investigación de Espana and by ERDF (European Regional Development Fund) A way of making Europe.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Interpreting deep learning models for glioma survival classification using visualization and textual explanations.

  • Osadebey, Michael
  • Liu, Qinghui
  • Emblem, Kyrre E.
  • Fuster García, Elíes|||0000-0002-0716-8960
[EN] Background Saliency-based algorithms are able to explain the relationship between input image pixels and deeplearning model predictions. However, it may be difcult to assess the clinical value of the most important image features and the model predictions derived from the raw saliency map. This study proposes to enhance the interpret¿ ability of saliency-based deep learning model for survival classifcation of patients with gliomas, by extracting domain knowledge-based information from the raw saliency maps. Materials and methods Our study includes presurgical T1-weighted (pre- and post-contrast), T2-weighted and T2-FLAIR MRIs of 147 glioma patients from the BraTs 2020 challenge dataset aligned to the SRI 24 anatomical atlas. Each image exam includes a segmentation mask and the information of overall survival (OS) from time of diag¿ nosis (in days). This dataset was divided into training (n = 118) and validation (n = 29) datasets. The extent of surgi¿ cal resection for all patients was gross total resection. We categorized the data into 42 short (mean µ = 157 days), 30 medium (µ = 369 days), and 46 long (µ = 761 days) survivors. A 3D convolutional neural network (CNN) trained on brain tumour MRI volumes classifed all patients based on expected prognosis of either short-term, mediumterm, or long-term survival. We extend the popular 2D Gradient-weighted Class Activation Mapping (Grad-CAM), for the generation of saliency map, to 3D and combined it with the anatomical atlas, to extract brain regions, brain volume and probability map that reveal domain knowledge-based information. Results For each OS class, a larger tumor volume was associated with a shorter OS. There were 10, 7 and 27 tumor locations in brain regions that uniquely associate with the short-term, medium-term, and long-term survival, respec¿ tively. Tumors located in the transverse temporal gyrus, fusiform, and palladium are associated with short, medium and long-term survival, respectively. The visual and textual information displayed during OS prediction highlights tumor location and the contribution of diferent brain regions to the prediction of OS. This algorithm design feature assists the physician in analyzing and understanding diferent model prediction stages. Conclusions Domain knowledge-based information extracted from the saliency map can enhance the interpret¿ ability of deep learning models. Our fndings show that tumors overlapping eloquent brain regions are associated with short patient survival., This work was supported by The European Union s Horizon 2020 Programmes ERC Grant Agreement No. 758657-ImPRESS, and Marie Skłodowska-Curie grant agreement (No 844646-GLIOHAB). The Norwegian Cancer Society and the Research Council of Norway Grants 303249, 261984, 325971. South-Eastern Norway Regional Health Authority Grants 2021057, 2013069, 2017073. Elies Fuster-Garcia was supported by Spanish State Research Agency, Subprogram for Knowledge Generation (PROGRESS, No PID2021-127110OA-I00).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Biomechanical mapping of tumor growth: A novel method to quantify glioma infiltration and mass effect

  • López-Mateu, Carlos
  • Gómez-Mahiques, María
  • Montosa-Micó, Víctor
  • Gil-Terrón-Rodríguez, Francisco Javier|||0000-0002-3536-6462
  • Garcia-Gomez, Juan M
  • Fuster García, Elíes|||0000-0002-0716-8960
  • Sederevicius, Donatas
  • Emblem, Kyrre E.
[EN] Background: Glioblastoma (GBM) growth can alter surrounding brain tissue through location-dependent physiological changes. Two main growth phenotypes¿(I) infiltrative, characterized by diffuse invasion with minimal mass effect, and (II) proliferative, characterized by pronounced tissue compression¿are recognized, but their quantitative characterization and prognostic impact remain poorly explored. Purpose: To develop and validate a novel MRI-based biomarker, the Dynamic Infiltration Rate (DIR), that quantitatively assesses the balance between tumor volume expansion and peritumoral compression, and to evaluate its prognostic ability for stratifying patients based on overall survival (OS). Methods: The DIR was defined as the ratio between tumor-volume enlargement and mass-effect-induced peritumoral compression. Technical validation was conducted using synthetic datasets with known ground truth spanning realistic infiltrative-proliferative spectra. Clinically, patients were dichotomized into high- and low-infiltration groups using a threshold optimized by maximizing the log-rank statistic for OS. Prognostic evaluation included multivariate Cox regression adjusted for age, sex, and MGMT methylation status. Results: The synthetic dataset validation demonstrated high concordance with ground truth (R² = 0.89). Clinical evaluation indicated significantly improved OS in the low DIR group (median = 35.2 weeks) compared to the high DIR group (median = 16.0 weeks; p = 0.0001). DIR effectively stratified patients based on survival (log-rank p < 0.001, HR = 2.49) and remained an independent prognostic factor on multivariate analysis (HR = 1.45, 95% CI 1.07¿1.85; p = 0.0159). Conclusions: The DIR is a novel and robust quantitative MRI biomarker capable of distinguishing between proliferative and infiltrative GBM phenotypes, independently predicting OS. Early phenotype identification could facilitate personalized treatment strategies and individualized follow-up scheduling., MCIN/AEI (Ministerio de Ciencia, Innovación y Universidades / Agencia Estatal de Investigación), Grant/Award Numbers: PID2024156848OB-I00, PID2021-127110OA-I00, PDC2025-165365-I00, FPU23/02431; Generalitat Valenciana, Grant/Award Numbers: INVEST/2022/298 (ProgramaINVESTIGO), CIAICO/2022/064(Lalaby-Glio), INNEST/2022/87(SINUÉ); European Research Council, Grant/Award Numbers: 758657-ImPRESS, 101213953-CHRONOS; Helse Sør-Øst RHF, Grant/Award Numbers: 2021057, 2017073, 2023050; Research Council of Norway, Grant/Award Numbers: 325971, 261984, 303249, 32543, 356066; Norwegian Cancer Society, Grant/Award Number: 309012 - SAFARI; Universitat Politècnica de València, Grant/Award Number: PAID-01-24(Subprogram1)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Quantification of Tissue Compression Identifies High-Grade Glioma Patients with Reduced Survival

  • Fuster García, Elíes|||0000-0002-0716-8960
  • Hovden, Ivar Thokle
  • Fløgstad Svensson, Siri
  • Larsson, Christopher
  • Vardal, Jonas
  • Bjørnerud, Atle
  • Emblem, Kyrre E.
[EN] The compression of peritumoral healthy tissue in brain tumor patients is considered a major cause of the life-threatening neurologic symptoms. Although significant deformations caused by the tumor growth can be observed radiologically, the quantification of minor tissue deformations have not been widely investigated. In this study, we propose a method to quantify subtle peritumoral deformations. A total of 127 MRI longitudinal studies from 23 patients with high-grade glioma were included. We estimate longitudinal displacement fields based on a symmetric normalization algorithm and we propose four biomarkers. We assess the interpatient and intrapatient association between proposed biomarkers and the survival based on Cox analyses, and the potential of the biomarkers to stratify patients according to their survival based on Kaplan¿Meier analysis. Biomarkers show a significant intrapatient association with survival (p < 0.05); however, only compression biomarkers show the ability to stratify patients between those with higher and lower overall survival (AUC = 0.83, HR = 6.30, p < 0.05 for CompCH). The compression biomarkers present three times higher Hazard Ratios than those representing only displacement. Our study provides a robust and automated method for quantifying and delineating compression in the peritumoral area. Based on the proposed methodology, we found an association between lower compression in the peritumoral area and good prognosis in high-grade glial tumors., This work was partially supported by: The European Research Council (ERC) under the European Union's Horizon 2020 (Grant Agreement No 758657), the South-Eastern Norway Regional Health Authority Grants 2017073 and 2013069, the Research Council of Norway Grants 261984 and 325971 (K.E.E.), The European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie (Grant Agreement No 844646), and South-Eastern Norway Regional Health Authority Grant 2021057 (E.F.G.).